Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
Clinical trial NCT05832216 · COMPLETED
Trial details
- NCT number
- NCT05832216
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2024-10-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.